<HTML><HEAD>
<TITLE>RBGMdb</TITLE>
</HEAD><BODY BGCOLOR="#ccccff" BACKGROUND="images/background.png">

<CENTER>
    	    	    	 <h1><a>RBGMdb</a></h1>
    	    	    <H1>Retinoblastoma Gene Mutation DataBase</H1>
    	    	      <H2>Query RBGMdb form</H2>
</CENTER>
<HR>
<CENTER><table><tr><td bgcolor="#ccccff"><center>
              <BOLD>RBGMdb Copyright (C) 2005</BOLD><BR>
                                  by<BR>
                      <EM>Angel Pesta&ntilde;a</EM><BR>

                  <TT>apestana@iib.uam.es</TT><BR>
</center></td></tr></table>
</CENTER>
<HR>


<TABLE WIDTH="90%" ALIGN="CENTER" CELLSPACING="18">
<TR><TH><CENTER><H2>RBDB</H2></CENTER></TH></TR>

<TR><TD BGCOLOR="lightgreen">
<blockquote>RBGMdb is an updated (as of 2005) Retinoblastoma Gene Mutation Database.
A manuscript describing it in more detail is in preparation. The data
collection is the result of work by Dr. A. Pesta&ntilde;a and his group.
The RDBMS implementation, search methods and update procedures are the
work of Dr. Jos&eacute; R. Valverde.</blockquote>
</TD></TR>
<TR><TD BGCOLOR="lightblue">
<h3>A short description of the database contents follows:</h3>

<dl>
<dt><strong>Location:</strong>
    <dd>Exon (E) and intron (I) number according to cDNA sequence NCBI 
    (NM_000321.1)

<dt><strong>Genomic:</strong>
    <dd>Description follows the recommendations published by Donnan and 
    Antonarakis (2000) using the genomic sequence GenBank: L11910.1

<dt><strong>cDNA:</strong> 
    <dd>changes as in Donnen and Antonarakis (2000), using the cDNA 
    sequence NCBI: NM_000321.1.

<dt><strong>Protein:</strong> 
    <dd>Deduced changes at the protein level follow the recommendatios of 
    Dunnen and Antonarakis (2000) usin the protein sequence NCBI: NP_000312.1.

<dt><strong>Consequences:</strong> 
    <dt>predicted consequences are as follows: 
    <ul>
    	<li><em>regulation</em> (promoter)</li>
	<li><em>FS</em> (trunckating frameshift)</li>
	<li><em>IF</em> (non-truncating inframe changes)</li>
	<li><em>MS</em> (missense changes)</li>
	<li><em>NS</em> (non-sense trunckating mutations)</li>
	<li><em>SP</em> (trunckating mutations affecting splicing sites)</li>
	<li><em>SP-IF</em> (in frame exon deletion due to splicing mutations)</li>
	<li><em>SP-MS</em> (mutations affecting the last two nucleotides in 
	exon can either be considered as  MS or splincing mutations.</li>
    </ul>

<dt><strong>Type of mutation:</strong>
    <dd><ul>
    	<li><em>DUP</em> (duplication)</li>
	<li><em>IN</em> (insertion)</li>
	<li><em>DE</em> (deletion)</li>
	<li><em>I_D</em> (complex insertion and deletion)</li>
	<li><em>PM</em> (point mutation).</li>
    </ul>
    
<dt><strong>Origin:</strong> 
    <dd>Germline or somatic.

<dt><strong>Sample:</strong>
    <dd><ul>
    	<li><em>PB</em> (peripheral blood for germline)</li>
	<li><em>retino</em> (retinoblastoma)</li>
	<li><em>other</em> (other  tumors).</li>
    </ul>

<dt><strong>Phenotype:</strong> 
    <dd><ul>
    	<li><em>B</em> (sporadic bilateral)</li>
	<li><em>BF</em> (bilateral familiar)</li> 
	<li><em>U</em> (sporadic unilateral)</li>
	<li><em>UF</em> (unilateral familiar)</li>
	<li><em>UMF</em> (unilateral multifocal)</li>
	<li><em>LP</em> (familiar with low penetrance).</li>
    </ul>

<dt><strong>Sex:</strong> 
    <dd><ul>
    	<li><em>F</em> (female)</li>
	<li><em>M</em> (male)</li>
    </ul>

<dt><strong>Age (months):</strong>
    <dd>Age at diagnosis or treatment in months.

<dt><strong>Country:</strong>
    <dd>Country  of origin of probands or of the main research group in 
    publications.

<dt><strong>References</strong>
    <dd>linked to PubMed.

<dt><strong>Patient_ID:</strong> 
    <dd>as reported in publication.

<dt><strong>Remarks:</strong> 
    <dd>any observation which can be useful in the context of a given mutation
</dl>
</TD></TR>
</TD></TR><TR><TD BGCOLOR="lightpink">
Questions and comments regarding the RBGMdb, including suggestions for
improvements and changes should be made to the author:<pre>
    Dr. Angel Pesta&ntilde;a
    Instituto de Investigaciones Biom&eacute;dicas, CSIC
    apestana@iib.uam.es
</pre>

Questions and comments regarding the database implementation and
web interfaces should be addressed to the author:<pre>
    Dr. Jos&eacute; R. Valverde
    Centro Nacional de Biotecnolog&iacute;a, CSIC
    jrvalverde@acm.org
</pre>
</TD></TR>
</TABLE>

</BODY>
</HTML>
